Juno, Millennium settle patent dispute over cancer drug Velcade
Biopharmalex 2019-09-30 11:56 amBy Miklos Bolza | Sydney
Please login to bookmark Close

Generic drug maker Juno Pharmaceuticals and US-based Millennium Pharmaceuticals have reached an in-principle settlement in their trans-Pacific dispute over two patents covering breakthrough anti-cancer medication Velcade.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au